Neogenomics (NEO) Other Gross PP&E Adjustments (2016 - 2025)
Neogenomics (NEO) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $210.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 4.92% year-over-year to $210.5 million, compared with a TTM value of $210.5 million through Dec 2025, up 4.92%, and an annual FY2025 reading of $210.5 million, up 4.92% over the prior year.
- Other Gross PP&E Adjustments was $210.5 million for Q4 2025 at Neogenomics, up from -$87.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $210.5 million in Q4 2025 and bottomed at -$127.3 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$34.5 million, with a median of -$97.0 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 129.22% in 2021, then increased 28.76% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $114.9 million in 2021, then rose by 17.98% to $135.5 million in 2022, then rose by 14.99% to $155.8 million in 2023, then rose by 28.76% to $200.6 million in 2024, then grew by 4.92% to $210.5 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for NEO at $210.5 million in Q4 2025, -$87.8 million in Q3 2025, and -$98.1 million in Q2 2025.